Teva Names Former Sandoz CEO Francis To Replace Schultz Within Weeks
Richard Francis Will Take Lead At Israeli Generics Giant From The Start Of 2023
Executive Summary
In just under six weeks Teva will have a new president and CEO, after former Sandoz chief Richard Francis was announced as Kåre Schultz’s replacement from the start of 2023.
You may also be interested in...
Teva Quits PhRMA As Financial, Policy Challenges Loom For The Brand/Generic Hybrid Giant
With a leadership position in the US generics association and a new CEO focused on how to reallocate resources, Teva leaves the brand trade association after a review of the ‘effectiveness and value of engagements.’
2022 Hires Reflect Global Challenges And Opportunities
Executive changes in 2022 reveal how the industry is adjusting to a volatile post-COVID environment.
Long-Awaited Nationwide Opioid Settlement To Move Forward For Teva
Teva has all but two US states on board for its long-hoped-for nationwide settlement to resolve opioid-related claims against the firm.